Dr. Bruner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 832-217-4513
Education & Training
Baylor College of MedicineFellowship, Neuropathology, 1982 - 1984
University of ToledoResidency, Pathology-Anatomic and Clinical, 1979 - 1982- The University of Toledo College of MedicineClass of 1979
Certifications & Licensure
TX State Medical License 1985 - 2025
OH State Medical License 1981 - 2017- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Neuropathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- 136 citationsIncreased levels of p21WAF1/Cip1 in human brain tumors.Jin-Myung Jung, Janet M. Bruner, Sanbao Ruan, L. A. Langford, Athanassios P. Kyritsis
Oncogene. 1995-11-16 - 728 citationsA phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseW. K. A. Yung, Robert E. Albright, Jeffrey J. Olson, R Fredericks, Karen Fink
British Journal of Cancer. 2000-09-01 - 292 citationsMulticenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapseMichael Brada, Khê Hoang-Xuan, R. Rampling, Pierre Yves Dietrich, Luc Dirix
Annals of Oncology. 2001-02-01
Journal Articles
- The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network InstitutionsJanet M. Bruner, Roger McLendon, Journal of Neuropathology & Experimental Neurology
Press Mentions
An Updated Histology Recode for the Analysis of Primary Malignant and Nonmalignant Brain and Other Central Nervous System Tumors in the Surveillance, Epidemiology, and End Results ProgramDecember 8th, 2020
Grant Support
- Core--LaboratoryNational Cancer Institute1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
